NCT00916669 - A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC) | Biotech Hunter

Timeline

Start Date

July 31, 2008

Primary Completion Date

July 31, 2010

Conditions

Small Cell Lung Cancer

Interventions

DRUG

Etoposide

Etoposide given as an infusion on day 1, day 2 and day 3 of a three-week cycle for a total of 6 cycles

DRUG

Cisplatin

Given as an infusion on day 1 of a three-week cycle for a total of 6 cycles

DRUG

enoxaparin sodium

Given as a subcutaneous injection in the abdomen daily during chemotherapy treatment and then continuing daily for 1 year. Dose will vary.

Trial Locations (4)

Massachusetts General Hospital, Boston

Dana-Farber Cancer Institute, Boston

Beth Israel Deaconess Medical Center, Boston

North Shore Medical Center, Peabody